Displaying drugs 14776 - 14800 of 14838 in total
Trifluperidol
Experimental
SD146
Experimental
Tozadenant
Tozadenant has been investigated for the basic science of Cocaine Dependence.
Investigational
Lofepramine
Experimental
Dihydroquinidine barbiturate
Experimental
Brostallicin
Investigational
ISIS 113715
ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant
reductions in LDL-cholesterol.
Investigational
RG-7795
Investigational
3,5-Dinitrocatechol
Experimental
Pyrrolnitrin
Experimental
4-Nitrocatechol
Experimental
Plinabulin
Investigational
Etonitazene
Experimental
Illicit
AR-AO-14418
Experimental
VLTS-589
VLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.
Investigational
BTA9881
BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
Investigational
CHGN111
CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
Displaying drugs 14776 - 14800 of 14838 in total